Saturday 17 October 2026 Export AGIO’s income statement to Excel — free account

Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $54.0 million, up 48.0% from fiscal 2024. In the quarter to June 2026, revenue grew 259.3%, EPS grew 12.4% and free cash flow grew 25.0%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

31.32 1.00 −3.09%

Follow AGIO

Alert me

Market cap: $1.9B
P/E: 0.0×
Fwd P/E: −4.6×
Dividend yield: —
F-score: 3/9
Altman Z: 8.12
Beneish M: −1.72
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	22.45	30.11	29.21	52.10
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(38.52)	(16.72)	(16.40)	(26.47)
P/B ratio Full definition →	2.15	1.79	1.32	1.82
Price to Tangible BV Full definition →	2.15	1.79	1.32	1.82
EV/Sales Full definition →	16.17	18.95	13.40	30.83
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	(4.41)	(3.29)	(1.94)	(3.37)
EV/FCF Full definition →	(4.35)	(3.25)	(1.92)	(3.34)
Quick Ratio Full definition →	9.08	12.80	10.52	12.81
Current Ratio Full definition →	10.22	14.19	11.46	13.82
Net Debt/EBITDA Full definition →	5.60	6.71	7.00	8.13
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.08	0.05	0.04	0.03
Operating CF/Net income Full definition →	0.57	1.20	0.89	0.85
Capex/Depreciation Full definition →	(5.43)	(3.51)	2.30	5.18
Research and Development Expense of Revenue Full definition →	225.17%	391.15%	441.01%	673.88%
Selling, General and Administrative Expense of Revenue Full definition →	115.20%	232.84%	258.48%	320.45%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	35.63%	74.91%	70.74%	96.09%
Graham Net Nets Full definition →	0.29	0.38	0.53	0.40
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(18.89%)	(21.43%)	(26.12%)	(17.39%)
Free Cash Flow Yield Full definition →	(16.54%)	(19.35%)	(23.91%)	(17.74%)
Revenue per Share Full definition →	0.75	0.35	0.34	0.22
Operating CF per Share Full definition →	(0.96)	(2.02)	(1.66)	(1.52)
Capex per Share Full definition →	(0.02)	(0.01)	(0.02)	(0.03)
Free Cash Flow per Share Full definition →	(0.98)	(2.04)	(1.68)	(1.54)
Cash per Share Full definition →	10.38	12.54	14.74	16.39
Shareholders Equity per Share Full definition →	17.25	18.87	20.58	22.09
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	17.25	18.87	20.58	22.09
Free Cash Flow Full definition →	(58.52)	(119.69)	(97.33)	(89.71)
Working Capital Full definition →	647.45	776.00	859.85	958.35
Capital Expenditures Full definition →	(1.21)	(0.77)	(1.12)	(1.55)
Net Current Asset Value Full definition →	635.27	758.97	837.94	931.73
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.03	0.04	0.06	0.12
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	12.55	9.74	7.34	4.07
Average Payables Full definition →	16.94	13.74	17.50	18.35
Average Inventory Full definition →	30.50	32.35	30.27	29.23
Average Assets Full definition →	1,289.83	1,370.25	1,480.21	1,588.75
Average Common Equity Full definition →	1,197.79	1,287.82	1,367.04	1,455.50

Show all line items

Columns are period end dates

Stockrow Weekly